Orbit Discovery raises US$7.6m in funding round led by Oxford sciences innovation

UK – Orbit Discovery, an oxford-based biopharma company, has raised $7.6m in funding to boost its peptide drug discovery services and accelerate the growth of its business. In this latest funding round Oxford Sciences Innovation led the event, with participation from Borealis Ventures, Perivoli Innovations and other institutional and individual investors. The funds raised will be used to accelerate Orbit’s ‘growth trajectory’ as a provider of peptide discovery services to the biotechnology and pharmaceutical industries. Orbit’s technology platform enables the screening of peptide libraries for target binding and subsequent activity…

Read More